Prevalence of suicide 40.0 per 100,000 person-years among those with epilepsy

Findings seen for those with recent suicidal thoughts and/or behaviors

Glucagon-like peptide 1 receptor agonist prescription linked to reduction in risk for suicidal ideation or attempts

Glucagon-like peptide 1 receptor agonist prescription linked to reduction in risk for suicidal ideation or attempts

ACEs contribute substantially to suicide attempts, seriously considering attempting suicide, prescription opioid misuse

Warnings for youth resulted in marked increases in psychotropic drug poisonings and suicide deaths

Additionally, a higher prevalence of lifetime suicide plan and attempts was observed

Population-based suicide care program also yields increase in rates of safety planning compared with usual care

Decline in age-adjusted suicide rate from 2018 to 2020 followed by increases in 2021 and 2022